MEDANTA Global Health Q3 FY25 results (Oct–Dec 2024) and concall
Global Health (Medanta) delivered a steady Q3 FY25, characterized by strong volume growth and significant margin outperformance in its developing hospitals. While matured hospitals grew at 10%, the Lucknow and Patna units are scaling rapidly with 64% occupancy. Management is aggressively expanding capacity with a 1,000-bed addition planned over the next two years and a long-term ₹3,000 crore capex plan for greenfield projects in Mumbai and Delhi.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 665 | 812 |
| EBITDA | 150 | 202 |
| Net profit | 104 | 131 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
